摘要
丙型肝炎病毒HCV是慢性肝炎、肝硬化以及肝细胞癌的主要原因。大量的研究指出许多能够在肝生理学上呈阳性结果的微型RNAs能够调节HCV感染或者被其调节。许多研究显示HCV利用宿主miRNAs 以及通过与HCV的RNA基因作用或者间接地控制于病毒复制相关的宿主通路从而调节HCV复制的表达,最终诱导与HCV相关的肝性疾病如肝纤维化、肝硬化或HCC。近期,在人类血清和血浆中检测到的细胞外miRNAs(循环miRNAs)被认为是病理条件下候选生物标记物,由于其性质非常稳定以及治疗的非侵入性。因为这些循环miRNAs, 大量的努力投入研究与HCV感染以及肝疾病相关的循环miRNAs模式的变化。本文综述了miRNAs在HCV相关的肝性疾病的发生和发展中的特点,并讨论了越来越多的那些能够区分与HCV感染和肝疾病相关的循环miRNA模式的证据。本文也强调了在HCV感染和相关疾病的诊断和预测中基于miRNA治疗形态和非侵入性生物标记物的进展。
关键词: 生物标记物,循环miRNAs
图形摘要
Current Drug Targets
Title:The Role of MicroRNA in Pathogenesis and as Markers of HCV Chronic Infection
Volume: 18 Issue: 7
关键词: 生物标记物,循环miRNAs
摘要: Hepatitis C virus (HCV) is a worldwide major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma (HCC). Accumulating evidence indicates that a number of microRNAs (miRNAs), which are able to exert an effect on liver biology and pathology, can regulate or be regulated by HCV infection. Many studies demonstrate that HCV utilizes host miRNAs and modulates expression of miRNAs in infected hepatocytes for its infection and propagation. In turn, host miRNAs can directly regulate HCV replication through interaction with the HCV RNA genome or by indirectly controlling the host pathways associated with the virus replication, which eventually induce HCV-related liver diseases such as liver fibrosis, hepatic cirrhosis, or HCC. Recently, extracellular miRNAs (circulating miRNAs) detected in human serum and plasma are proposed as biomarker candidates for pathological conditions due to their remarkably stable nature and the non-invasiveness of their detection. Since these circulating miRNAs exhibit consistent levels between healthy individuals but significantly changed profiles in disease conditions, considerable effort has been employed to investigate the alteration in the circulating miRNA pattern that is related with HCV infection and associated liver diseases. In this review, we summarize the features of miRNAs critical for HCVassociated liver disease initiation and progress, and discuss growing evidence that distinctive circulating miRNA patterns are related with HCV infection and associated liver diseases. These will shed light on the development of miRNA-based therapeutic modalities and non-invasive biomarkers for the diagnosis and prognosis of HCV infection and associated diseases.
Export Options
About this article
Cite this article as:
The Role of MicroRNA in Pathogenesis and as Markers of HCV Chronic Infection, Current Drug Targets 2017; 18 (7) . https://dx.doi.org/10.2174/1389450117666160401125213
DOI https://dx.doi.org/10.2174/1389450117666160401125213 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Tumor Stem Cell Niches: A New Functional Framework for the Action of Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Antiproliferative Activity of Cobra Venom Cytotoxins
Current Topics in Medicinal Chemistry Bid Stands at the Crossroad of Stress-Response Pathways
Current Cancer Drug Targets Antimicrobial Activity of New 2-Thioxo-benzo[g]quinazolin-4(3H)-one Derivatives
Medicinal Chemistry Molecular and Cellular Activities of Vitamin E Analogues
Mini-Reviews in Medicinal Chemistry Neuroprotection by Natural Polyphenols: Molecular Mechanisms
Central Nervous System Agents in Medicinal Chemistry OX40 and OX40L Interaction in Cancer
Current Medicinal Chemistry The Chlorophyll Catabolite Pheophorbide a as a Photosensitizer for the Photodynamic Therapy
Current Medicinal Chemistry Clinical Trial Update and Novel Therapeutic Approaches for Metastatic Prostate Cancer
Current Medicinal Chemistry Host Pharmacogenetics in the Treatment of HIV and Cancer
Current Drug Safety Application of Nanotechnology in the Treatment and Diagnosis of Gastrointestinal Cancers: Review of Recent Patents
Recent Patents on Anti-Cancer Drug Discovery Metabolism and Mechanism of Human Cytochrome P450 Enzyme 1A2
Current Drug Metabolism Influence of New Synthetic Xanthones on the Proliferation and Migration Potential of Cancer Cell Lines In Vitro
Anti-Cancer Agents in Medicinal Chemistry The Development of Future Research Strategies from Reviewing Antiemetic Trials for Chemotherapy Induced Emesis
Reviews on Recent Clinical Trials Anti-tumorigenic Efficacy of Tangeretin in Liver Cancer – An In Silico Approach
Current Computer-Aided Drug Design Genetics of Cancer Susceptibility
Current Genomics Ribonucleases, Nucleases and Antiangiogenins in Antiproliferative Activities
Current Signal Transduction Therapy Synthesis and Anti-tumor Activities of Novel Phenyl Substituted Suberoylanilide Hydroxamic Acid Derivatives Against Human Cancer Cells
Medicinal Chemistry Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays
Anti-Cancer Agents in Medicinal Chemistry Senescence and Cell Death Pathways and Their Role in Cancer Therapeutic Outcome
Current Medicinal Chemistry